Inspire Medical Systems, Inc. (INSP)

Name: Inspire Medical Systems, Inc. (INSP) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001609550 · NYSE · Surgical & Medical Instruments & Apparatus

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, Inspire Medical Systems, Inc. reported revenue of $911.98M. Revenue grew 13.6% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $898.74M.

Key ratios (year ended 2025-12-31)

85.4%

Gross margin

5.6%

Operating margin

15.9%

Net margin

18.6%

Return on year-end equity

13.6%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-16

Headquarters locality: Maple Grove · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$898.74M	$911.98M	$802.80M	$624.80M	$407.86M	$233.39M	$115.38M	$82.05M	$50.59M	$28.57M	$16.43M
Cost of Revenue	$124.64M	$133.22M	$122.99M	$96.58M	$66.11M	$33.28M	$17.62M	$13.64M	$10.06M	$6.02M	$3.90M
Gross Profit	$774.11M	$778.76M	$679.82M	$528.22M	$341.74M	$200.12M	$97.76M	$68.41M	$40.54M	$22.55M	$12.52M
R&D Expense	$99.68M	$103.17M	$114.13M	$116.54M	$68.64M	$37.35M	$26.09M	$12.84M	$7.39M	$6.19M	$7.09M
Operating Income	$54.12M	$50.95M	$36.08M	-$40.27M	-$47.59M	-$39.85M	-$56.21M	-$34.90M	-$20.38M	-$16.00M	-$17.25M
Depreciation & Amortization	$17.21M	$13.96M	$6.55M	$2.85M	$1.86M	$1.22M	$840.0K	$495.0K	$393.0K	$285.0K	$103.0K
EBITDA	$71.33M	$64.91M	$42.63M	-$37.42M	-$45.73M	-$38.63M	-$55.37M	-$34.40M	-$19.98M	-$15.72M	-$17.15M
Net Income	$135.04M	$145.42M	$53.51M	-$21.15M	-$44.88M	-$42.04M	-$57.20M	-$33.24M	-$21.83M	-$17.51M	-$18.53M
EPS (Diluted)	n/a	$4.89	$1.75	-$0.72	-$1.60	-$1.54	-$2.19	-$1.40	n/a	n/a	n/a
Total Assets	$925.99M	$907.32M	$808.38M	$676.81M	$564.88M	$295.08M	$281.19M	$181.25M	$200.08M	$25.09M	n/a
Total Liabilities	$100.41M	$126.16M	$118.69M	$104.30M	$68.87M	$66.04M	$51.44M	$41.42M	$36.08M	$23.76M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	$24.50M	$24.50M	$24.50M	$24.50M	n/a	n/a
Shareholders' Equity	$825.58M	$781.16M	$689.70M	$572.51M	$496.01M	$229.05M	$229.75M	$139.84M	$164.00M	$1.33M	-$6.61M
Cash & Equivalents	$127.76M	$104.81M	$150.15M	$185.54M	$441.59M	$214.47M	$190.52M	$22.86M	$97.29M	$8.96M	$6.68M
Operating Cash Flow	$157.07M	$116.98M	$130.25M	$24.65M	$11.57M	-$20.12M	-$53.05M	-$32.85M	-$18.69M	-$15.79M	-$17.95M
Capital Expenditures	$39.98M	$38.50M	$39.12M	$23.63M	$9.10M	$4.67M	$2.46M	$2.74M	$250.0K	$412.0K	$306.0K
Free Cash Flow	$117.09M	$78.48M	$91.12M	$1.02M	$2.47M	-$24.79M	-$55.50M	-$35.59M	-$18.94M	-$16.20M	-$18.25M
Share Repurchases	$100.01M	$175.02M	$0	$0	$0	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding	28.91M	28.58M	29.74M	29.56M	29.01M	27.42M	27.07M	24.11M	23.40M	1.27M	n/a
Weighted Average Diluted Shares	n/a	29.76M	30.54M	29.30M	28.07M	27.26M	26.07M	23.80M	n/a	n/a	n/a
EPS (Basic)	n/a	$4.95	$1.80	-$0.72	-$1.60	-$1.54	-$2.19	-$1.40	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView